AZN
AstraZeneca PLC
Stock
$156.90−0.80 (−0.51%)Close Oct 2, 2026
- Research and development, 2025
- $14.2B
- YoY, 2025
- +4.8%
- 5-year CAGR
- +18.9%
- 10-year CAGR
- +9.0%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $14.2B | +4.8% |
| 2024 | $13.6B | +24.2% |
| 2023 | $10.9B | +12.0% |
| 2022 | $9.8B | +0.3% |
| 2021 | $9.7B | +62.5% |
| 2020 | $6.0B | −1.1% |
| 2019 | $6.1B | +2.1% |
| 2018 | $5.9B | +3.0% |
| 2017 | $5.8B | −2.3% |
| 2016 | $5.9B | −1.8% |
| 2015 | $6.0B | — |